Results 211 to 220 of about 112,750 (251)

Angiotensin-Converting Enzyme Inhibitors

AACN Advanced Critical Care, 1992
The angiotensin-converting enzyme (ACE) inhibitors available today include Captopril (Capoten), enalapril (Vasotec), enaloprilat (Vasotec IV), lisinopril (Prinivil, Zestril), benazepril (Lotensin), fosinopril (Monopril), and ramipril (Atace). These drugs are used in the treatment of hypertension and congestive heart failure.
openaire   +2 more sources

The Future of Angiotensin-Converting Enzyme Inhibitors

Journal of Cardiovascular Pharmacology, 1985
After a brief introduction summarizing their historical development and the classification of angiotensin-converting enzyme inhibitors by chemical structure, the considerations involved in developing new and improved drugs of this pharmacologic class are discussed.
openaire   +2 more sources

Angiotensin Converting Enzyme Inhibitors and Cough

Journal of Cardiovascular Pharmacology, 1989
Angiotensin converting enzyme (ACE) inhibitors produce a dry, nonproductive cough in some patients. Retrospective surveys have suggested an incidence of cough of between 0.7 and 14%. Those patients who develop cough show a marked increase in the sensitivity of the cough reflex to inhalation of the extract of red pepper, capsaicin.
J R, McEwan, R W, Fuller
openaire   +2 more sources

Angiotensin Converting Enzyme (ACE) Inhibitors

Annual Review of Pharmacology and Toxicology, 1982
Angiotensin converting enzyme inhibitors represent a new class of agents which were designed to retain only that unique property. Because of this inhibition, administration of these agents results in the significant reduction of elevated blood pressure of various etiologies and in the amelioration of symptoms associated with congestive heart failure ...
openaire   +2 more sources

Angiotensin-Converting Enzyme Inhibitor Angioedema

The Journal of Emergency Medicine, 2012
*Department of Emergency Medicine, University of Michigan/St. Joseph Mercy Emergency Medicine Residency, Ann Arbor, Michigan, and †Department of Emergency Medicine, University of Michigan Health System, Ann Arbor, Michigan Reprint Address:Michaelina R. Bolton, MD, Department of Emergency Medicine, University of Michigan Health System, 1500 E.
Michaelina R, Bolton, Suzanne L, Dooley-Hash   +1 more
openaire   +2 more sources

Angiotensin-Converting Enzyme (ACE) Inhibitors

2015
Angiotensin converting enzyme inhibitors represent a new class of agents which were designed to retain only that unique property. Because of this inhibition, administration of these agents results in the significant reduction of elevated blood pressure of various etiologies and in the amelioration of symptoms associated with congestive heart failure ...
Daniel Thomas Ginat, Jason M. Johnson
openaire   +1 more source

Angiotensin-Converting Enzyme Inhibitors in Veterinary Medicine

Current Pharmaceutical Design, 2007
Angiotensin-converting enzyme (ACE) inhibitors represent one of the most commonly used categories of drugs in canine and feline medicine. ACE inhibitors currently approved for use in veterinary medicine are benazepril, enalapril, imidapril and ramipril. They are all pro-drugs administered by oral route. A physiologically based model taking into account
Lefebvre, Hp, Brown, Sa, Chetboul, Valérie, King, Jn, Pouchelon, Jl, Toutain, Pierre-Louis   +5 more
openaire   +3 more sources

Clinical applications of angiotensin-converting enzyme inhibitors

The American Journal of Medicine, 1984
Although only recently introduced, angiotensin-converting enzyme inhibitors have been utilized to treat a wide variety of clinical disorders. Their uses to date, approved by the Food and Drug Administration, have been in the treatment of refractory hypertension and congestive heart failure.
R K, Ferguson, P H, Vlasses, H H, Rotmensch   +2 more
openaire   +2 more sources

Overview of the angiotensin-converting-enzyme inhibitors

American Journal of Health-System Pharmacy, 2000
The pharmacology of angiotensin-converting-enzyme (ACE) inhibitors and their role in the renin-angiotensin system (RAS) are described, and pharmacokinetic properties and common adverse events are presented. ACE inhibitors play a vital role in the RAS by regulating the potent vasoconstrictor angiotensin II.
openaire   +2 more sources

Angiotensin converting enzyme inhibitors in pregnancy

Seminars in Perinatology, 1997
Angiotensin converting enzyme (ACE) inhibitors are excellent antihypertensive agents and are becoming widely used as first-line therapy for chronic hypertension in women of reproductive age owing to their efficacy and few side effects. Reports of adverse fetal and neonatal effects from the use of ACE inhibitors in pregnancy in both animal and human ...
openaire   +2 more sources